4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-14-002288
CIK 0001316175operating
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 9:57 PM ET
Size
9.0 KB
Accession
0001214659-14-002288
Insider Transaction Report
Form 4
LIU MAY
Chief Accounting Officer
Transactions
- Award
Common Stock
2014-03-25−3,625→ 7,302 total - Award
Stock Option (right to buy)
2014-03-25+6,745→ 6,745 totalExercise: $3.30From: 2014-03-25Exp: 2024-03-25→ Common Stock (6,745 underlying) - Tax Payment
Common Stock
2014-03-25$3.30/sh−529$1,746→ 3,677 total
Footnotes (5)
- [F1]Shares forfeited in lieu of payment of tax liability in connection with the vesting of 1,175 performance shares, which represent the portion of the Reporting Person?s 2012 performance share award.
- [F2]Shares have been adjusted to reflect the issuer?s 1-for-8 reverse split effectuated on July 15, 2013.
- [F3]Award of Restricted Stock Units under the Issuer's 2013 Stock Option and Incentive Plan that vest immediately on March 25, 2014.
- [F4]Not applicable.
- [F5]The Stock Option vests immediately on 3/25/2014.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 9:57 PM ET
- Size
- 9.0 KB